TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03044795 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT03044795 — Predictive Biomarker (PRD): TP53BP1 mRNA
Genes: TP53BP1
Study NCT03044795 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT00182650 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00182650 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01661946 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01205750 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03634384 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT00050479 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04147507 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01333969 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04452916 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03846973 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00897091 — Predictive Biomarker (PRD): CHAF1A mRNA
Genes: CHAF1A; CAF; CAF1P150
Study NCT00897091 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03094611 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT02553733 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03947112 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03196778 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT01771354 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03966313 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03966313 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT03682744 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04492384 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02923284 — Predictive Biomarker (PRD): AQP1 mRNA
Genes: AQP1; CHIP28
Study NCT02657343 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04898179 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00240266 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03201614 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03821922 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT00224549 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00224549 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00224549 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01660776 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00877656 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00019448 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03386929 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03386929 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03386929 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT03386929 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03386929 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02129621 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT03952195 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT03442504 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT04278781 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT00515229 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03140969 — Predictive Biomarker (PRD): CEP290 mRNA
Genes: CEP290; BBS14; KIAA0373; NPHP6
Study NCT01969058 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03519880 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT01146197 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03083405 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00350831 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT00673296 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00673296 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04486716 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04486716 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01888237 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT02741167 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03272334 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02759510 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00966199 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04543162 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT02730767 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02730767 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02730767 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02730767 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02499237 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03134235 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03134235 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03134235 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT06714019 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT01163942 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03599765 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study NCT01171924 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01171924 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00114803 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01207908 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01796847 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04300933 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00208104 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03539614 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01483287 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT03386162 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03386162 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03386162 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03386162 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05424588 — Predictive Biomarker (PRD): MYOD1 mRNA
Genes: MYOD1; BHLHC1; MYF3; MYOD
Study NCT01831908 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03470987 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03470987 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03784963 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03784963 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03784963 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study NCT04438824 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT00694863 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03319017 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00005038 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01514357 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT02137343 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01232140 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01232140 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04565249 — Predictive Biomarker (PRD): PLN mRNA
Genes: PLN; PLB
Study NCT06630481 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT03646370 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01403519 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00895167 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT02752035 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02268071 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03211624 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT02562911 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03572283 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03572283 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT02891356 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03070665 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01379690 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03702309 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02322385 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT02322385 — Predictive Biomarker (PRD): PKD2 mRNA
Genes: PKD2; TRPP2
Study NCT01815515 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02082977 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT03589833 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02929732 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01343173 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01343173 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01965847 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02665377 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT02665377 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03361631 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00330733 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00330733 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00240019 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00661856 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00091975 — Surrogate Endpoint (SUR): Serum intact parathyroid hormone
Study NCT00091975 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT03379870 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT03269019 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00147355 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04103671 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04103671 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03683433 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT00319085 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04430738 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05535569 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT00927823 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00927823 — Predictive Biomarker (PRD): MTOR mRNA
Genes: MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1
Study NCT00957086 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03189524 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT03731429 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01585025 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study NCT01585025 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT04432779 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03552029 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00734032 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT01927614 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT01900184 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03136523 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03136523 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03136523 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study NCT03136523 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03136523 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03136523 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT03136523 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04900155 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04900155 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01568879 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00654602 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03981510 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02074111 — Predictive Biomarker (PRD): RNF213 mRNA
Genes: RNF213; ALO17; C17orf27; KIAA1554; KIAA1618; MYSTR
Study NCT00443456 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00950521 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00553254 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00553254 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00553254 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04164901 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04164901 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT06169904 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06169904 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT06169904 — Predictive Biomarker (PRD): VTCN1 mRNA
Genes: VTCN1; B7H4; UNQ659/PRO1291
Study NCT00952692 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01927913 — Predictive Biomarker (PRD): Liver iron
Study NCT03009188 — Predictive Biomarker (PRD): FOXC1 mRNA
Genes: FOXC1; FKHL7; FREAC3
Study NCT03009188 — Predictive Biomarker (PRD): PITX2 mRNA
Genes: PITX2; ARP1; RGS; RIEG; RIEG1
Study NCT04256941 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04256941 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04256941 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04256941 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03856164 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT02480335 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01417767 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04049513 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01360840 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT02978495 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00244985 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03236545 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT00741377 — Predictive Biomarker (PRD): DKK1 mRNA
Genes: DKK1; UNQ492/PRO1008
Study NCT00741377 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03282266 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00286741 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04369807 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04429763 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00939848 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00939848 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02659241 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04354857 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02422108 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT02422108 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT04614337 — Predictive Biomarker (PRD): LUM mRNA
Genes: LUM; LDC; SLRR2D
Study NCT00561379 — Predictive Biomarker (PRD): FCGR3A mRNA
Genes: FCGR3A; CD16A; FCG3; FCGR3; IGFR3
Study NCT03569683 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01174563 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02860260 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02860260 — Safety Biomarker (SAF): BDNF
Study NCT01511250 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04316143 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02107014 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03802396 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT00608907 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04590794 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT03802786 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00543127 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04360941 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04360941 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04360941 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06261255 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT03875248 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00286663 — Predictive Biomarker (PRD): SLA mRNA
Genes: SLA; SLAP; SLAP1
Study NCT04081506 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02559921 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02779231 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00321932 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02753972 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02753972 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03439488 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00246103 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01678742 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03721289 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04448379 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04305210 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04214509 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT00006413 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03319251 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT03319251 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00800644 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03638375 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03099824 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT03537651 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02678533 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02678533 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01362179 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01155050 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00284128 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01224314 — Surrogate Endpoint (SUR): Serum potassium
Study NCT01224314 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03931551 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04617860 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT04189614 — Predictive Biomarker (PRD): PTK7 mRNA
Genes: PTK7; CCK4
Study NCT00132717 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04554953 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02836249 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02600442 — Predictive Biomarker (PRD): Proliferation marker protein Ki-67
Genes: MKI67
Study NCT04578379 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study NCT01924819 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03469895 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT02259595 — Predictive Biomarker (PRD): HPN mRNA
Genes: HPN; TMPRSS1
Study NCT03926338 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT03114865 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03798210 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02692027 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00460213 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03018873 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF